|
Summary Information: Enanta Pharmaceuticals Inc. Common Stock NASDAQ:ENTA |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. Enanta's research and development efforts have produced clinical candidates for the following disease targets: respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH) and hepatitis B virus (HBV). Enanta is also conducting research in human metapneumovirus (hMPV) and emerging coronaviruses, including SARS-CoV-2.
__The following are links to various summary and news pages for __Enanta Pharmaceuticals Inc. Common Stock [ ENTA ]. __Note: Some Links might not have information for the company. |
|